Mikaela M. Hofer, Pharm.D., (@mikaelamhofer) identifies risk factors associated with postpartum depression, reviews current options for treatment and describes the potential place in therapy for brexanolone in treating postpartum depression.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.